ArticleTobacco induced diseases2024
A cross-sectional study on exposure to secondhand smoke in indoor public places and attitudes of residents towards the smoke control ordinance in public places.
Article in Tobacco induced diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative analysis of early-onset and late-onset esophageal cancer burden in China, 1990-2021: based on the 2021 Global Burden of Disease Study.Esophagus : official journal of the Japan Esophageal Society · 2026Article
- The associated factors of smoking cessation intention among husbands in gestational households: A census-based cross-sectional survey.Tobacco induced diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSecondhand smoke (SHS) exposure is a serious public health problem. This study aims to collect data on tobacco control since the implementation of the new version of the Smoke Control Ordinance in Public Places of Hangzhou (the Ordinance), combined with questionnaire surveys to understand the SHS exposure situation in public places, relevant knowledge and attitudes of residents in Hangzhou.
methodsWe used data from a population-based tobacco control survey of 2746 adults aged 15-75 years conducted in Hangzhou, Zhejiang Province in March 2023. Data were collected using a self-administered questionnaire consisting of demographic characteristics, exposure to tobacco, awareness of tobacco hazards, knowledge of the Ordinance, and behaviors and attitudes towards tobacco control in public places. Chi-squared tests were performed to examine the differences in knowledge and attitudes related to tobacco control in indoor public places among residents with different characteristics in Hangzhou. Multivariable logistic regression was used to identify variables affecting satisfaction with the effectiveness of tobacco control in public places.
resultsOf the 2155 non-smokers, 1006 (46.68%) had been exposed to SHS in public places. More than 89.00% of participants supported the Ordinance. Satisfaction with effectiveness of tobacco control in public places in Hangzhou was 68.54%, and the subcomponents that influenced it were satisfaction with tobacco control publicity campaigns (AOR=1.85; 95% CI: 1.19-2.88), satisfaction with tobacco control surveillance and enforcement (AOR=3.91; 95% CI: 2.43-6.30), satisfaction with the smoke-free demonstration for government departments (AOR=5.79; 95% CI: 3.96-8.47), and satisfaction with individual tobacco control behavior (AOR=11.68; 95% CI: 8.53-15.99).
conclusionsIt is necessary to strengthen tobacco control publicity to increase the participation of residents and to gain a deeper understanding of the subjective willingness and needs of residents to participate in tobacco control campaigns in order to improve residents' individual satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.